5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics.

      Journal of Pediatric Surgery
      Acidosis, Lactic, diagnosis, drug therapy, etiology, therapy, Adult, Anti-Bacterial Agents, therapeutic use, Bifidobacterium, Consciousness Disorders, Dysarthria, Gait Disorders, Neurologic, Humans, Kanamycin, Lactobacillus casei, Male, Probiotics, Short Bowel Syndrome, complications, microbiology

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          D-lactic acidosis sometimes occurs in malabsorbed patients with short-bowel syndrome and is characterized by recurrent episodes of encephalopathy and metabolic acidosis. The characteristic neurologic abnormalities and the presence of metabolic acidosis raises a diagnostic suspicion, and the diagnosis is made when the serum level of D-lactic acid is greater than 3 mmol/L. Standard treatment consists of restricting oral carbohydrates or fasting, correction of metabolic acidosis, and a long-term suppression of pathogenic floras with antibiotics. The authors present a case of D-lactic acidosis in a 22-year-old patient with short-bowel syndrome, to whom intestinal bacterial agents (probiotics) were given in addition to oral kanamycin. Recolonization of the intestine with nonpathogenic floras should be a long-term treatment for D-lactic acidosis.

          Related collections

          Author and article information

          Comments

          Comment on this article